Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon-free direct-acting antiviral therapy (2014-2018)

Document Type

Article

Publication Date

2-11-2022

Publication Title

Clinical infectious diseases

Abstract

We compared rates of emergency department (ED) visits and hospitalizations between HCV patients who achieved sustained virological response (SVR) after direct-acting antiviral (DAA) therapy (cases) to matched controls. Among 3049 pairs, cases demonstrated lower rates of liver-related ED visits (P=.01) than controls; all-cause and liver-related hospitalization rates and hospitalized days were also lower in cases (P<.0001).

Medical Subject Headings

Antiviral Agents/therapeutic use; Emergency Service; Hospital; Hepacivirus; Hepatitis C; Chronic/drug therapy/epidemiology; Hospitalization; Humans; Interferons/therapeutic use; Ribavirin/therapeutic use; Sustained Virologic Response; Treatment Outcome; Ed; Hcv; Svr; healthcare utilization; race

PubMed ID

35147184

ePublication

ePub ahead of print

Volume

75

Issue

8

First Page

1453

Last Page

1456

Share

COinS